Stem cells and hepatic cirrhosis

Panminerva Medica

Volumn 52, Issue 2, 2010, Pages 149-165

  Chen, Z ^a   Qi, L Z ^b   Zeng, Z R ^c   Li, H Y ^d   Dai, L J ^d  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b First Hospital of Qingdao Techno economy   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Liver cirrhosis; Regenerative medicine; Stem cells

Indexed keywords

ANIMAL; EXTRACELLULAR MATRIX; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77955443018     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. BatallerR, Brenner D. Liver fibrosis. J Clin Invest 2005;115:209-218
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-851
3. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134:1641-1654
4. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003;362:2089-2094
5. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-2100
6. Guo J, Friedman SL. Hepatic fibrogenesis. Semin Liver Dis 2007;27:413-426
7. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172
8. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
9. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004;39:273-278
10. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-2048
11. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 2001;158:1239-1244
12. Dai LJ, Li HY, Guan LX, Ritchie G, Zhou JX. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res 2009;2:16-25.
13. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
14. Higuchi H, Gores GJ. Mechanisms of liver injury: an overview. Curr Mol Med 2003;3:483-490
15. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PR Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a diatary murine model. Am J Phsiol Gastrointest Liver Physiol 2004;287:G264-73.
16. Viñas O, Bataller R, Sancho-Bru P, Ginès P, Berenguer C, Enrich C et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003;38:919-929
17. Arthur MJ, 2002. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122: 1525-1528
18. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004;126:1795-1808
19. Friedman SL. Reversibility of hepatic fibrosis and cirrhosis - is it all hype? Nat Clin Pract Gastroenterol Hepatol 2007;4:236-237
20. Alison MR, Islam S, Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly J Pathol 2009;217:282-298
21. Takubo K, Izumiyama-Shimomura N, Honma N, Sawabe M, Arai T, Kato M et al. Telomere lengths are characteristic in each human individual. Exp Gerontol 2002;37:523-531
22. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T et al. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 2000;256:578-582
23. Alison MR, Islam S, Lim SM. Cell therapy for liver disease. Curr Opin Mol Ther 2009; 11:364-374
24. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
25. Sipe JD. Tissue engineering and reparative medicine. Ann N Y Acad Sci 2002;961:1-9.
26. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990;110:1001-1020
27. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008;135:438-450
28. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151:1273-1280 (Pubitemid 27479757)
29. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994;263:1149-1152
30. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J, et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis FASEB J 2002;16:935-942
31. Murphy F, Iredale J. The telomere hypothesis for progressive liver cirrhosis. J Hepatol 2003;38:378-379.
32. Petersen BE, Zajac VF, Michalopoulos GK. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998;27:1030-1038
33. Gordon GJ, Coleman WB, Hixson DC, Grisham JW. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 2000; 156: 607-619
34. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213: 286-300.
35. Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007;18:819-826
36. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy Cell Tissue Res 2008;331:271-282
37. Matas AJ, Sutherland DE, Steffes MW, Mauer SM, Sowe A, Simmons RL et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science 1976;192:892-894
38. Yoshida Y, Tokusashi Y, Lee GH, Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 1996; 111:1654-1660
39. Wiederkehr JC, Kondos GT, Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 1990;50:466-471
40. de Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998;95:282-287
41. Michel JL, Rabier D, Rambaud C, Kamoun P, Brousse N, Vassault A et al. Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency. Chirurgie 1993-1994; 119:666-671
42. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992;24:3052-3053
43. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338: 1422-1426
44. HorslenSP, McCowanTC, Goertzen TC, Warkentin PI, CaiHB, Strom SC, Fox IJ. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003; 111:1262-1267
45. Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003;76:735-738
46. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P et al. Hepatocyte transplantation as a treatment for glycogen storage disease type la. Lancet 2002;359:317-318
47. Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: state of art. J Internal Med 2009;266:339-357
48. Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J et al. Hepatocyte transplantation in acute liver failure. Liver Transpl 2000;6:32-40.
49. Schneider A, Attaran M, Meier PN, Strassburg C, Manns MP, Ott M, et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 2006;82:1115-1116
50. Strom SC, Fisher RA, Thompson MT, SanyalAJ, ColePE, Ham JM, Posner MP. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63:559-569
51. Stéphenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 2005;5:2058-2061
52. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999;154:537-541
53. Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, Theise ND. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 2005;41:1252-1261
54. Alison MR, Vig P, Russo F, Bigger BW, Amofah E, Themis M, Forbes S. Hepatic stem cells: from inside and outside the liver? Cell Prolif 2004;37:1-21.
55. Golding M, Sarraf CE, Lalani EN, Anilkumar TV, Edwards RJ, Nagy P etal. Oval cell differentiation into hepatocytes in the acety-laminofluorene-treated regenerating rat liver. Hepatology 1995;22:1243-1253
56. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001; 120:534-544
57. Yasui O, Miura N, Terada K, Kawarada Y, Koyama K, Sugiyama T. Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology 1997;25:329-334
58. Li WL, Su J, Yao YC, Tao XR, Yan YB, Yu HY et al. Isolation and characterization of bipotent liver progenitor cells from adult mouse. Stem Cells 2006;24:322-332
59. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204:1973-1987
60. Shupe TD, Piscaglia AC, Oh SH, Gasbarrini A, Petersen BE. Isolation and characterization of hepatic stem cells, or "oval cells," from rat livers. Methods Mol Biol 2009;482:387-405.
61. Flohr TR, Bonatti H Jr, Brayman KL, Pruett TL. The use of stem cells in liver disease. Curr Opin Organ Transplant 2009;14:64-71.
62. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N et al. Bone marrow as potential source of hepatic oval cells. Science 1999;284,1168-1170
63. Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L et al. Liver from bone marrow in humans. Hepatology 2000;32:11-16
64. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257.
65. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147
66. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M et al. Human mesenchymal stem cells xenografted directly to rat are differentiated into human hepatocytes without fusion. Blood 2005; 106:756-763
67. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, LundT et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002; 109:1291-1302 (Pubitemid 34546893)
68. Lange C, Bassler P, Lioznov MV, Brans H, Kluth D, Zander AR, Fiegel HC. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol 2005; 11: 4497-4504 (Pubitemid 41150389)
69. Ong SY, Da H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials 2006a;27: 4087-4097
70. Raikwar SP, Zavazava N. Insulin producing cells derived from embryonic stem cells: are we there yet? J Cell Physiol 2009;218: 256-283
71. Sancho-Bru P, Najimi M, Caruso M, Pauwelyn K, Cantz T, Forbes S et al. Stem and progenitor cells for liver repopulation: can we standardize the process from bench to bedside? Gut 2009;58:594-603.
72. Yamamoto H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, Ochiya T. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 2003;37:983-993
73. Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006;44: 1478-1486
74. Ishii T, Yasuchika K, Machimoto T, Kamo N, Komori J, Konishi S et al. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells 2007;25:3252-3260
75. Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007;45:1229-1239 (Pubitemid 46775786)
76. Lavon N, Yanuka O, Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 2004;72:230-238 (Pubitemid 41702132)
77. Choi D, Oh HJ, Chang UJ, Koo SK, Jiang JX, Hwang SY et al. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant 2002; 11:359-368
78. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1997;385:810-813
79. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676
80. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cells from adult human somatic cells. Science 2007;318,1917-1920
81. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146
82. Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;in press
83. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent sten cells. Cell Stem Cell 2008;4:595-605.
84. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and trans-gene sequences. Science 2009;324:797-801.
85. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-384
86. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-632
87. Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM et al. Functional integration of hepatocyrtes derived from human mesenchymal stem cells into mouse livers. Gut 2007;56:405-415
88. Zhang ZX, Guan LX, Zhang K, Zhang Q, Dai LJ. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy 2008; 10:134-139
89. Fang B, Sh M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplant 2004;78:83-88
90. Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006;45:144-159
91. Fischer UM, Halting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cell Dev 2009;18:683-692
92. Xiang GA, Zhang GQ, Fang CH, Gao P, Chen KY. 2005. A preliminary study of the homing capacity of allograft mesenchymal stem cells to rat liver. Di Yi Junyi Daxue Xuebao 2005;25:994-997
93. Fox JM, Chamberlain G, Ashton BA, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007;137:491-502.
94. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1 a plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110: 3300-3305
95. Wang L, Li Y, Gautam SC, Zhang Z, Lu M, Chopp M. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 2002;30:831-836 (Pubitemid 34831705)
96. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006;24:1030-1041
97. Benten D, KumaranV, Joseph B, Schattenberg J, PopovY, Schuppan D, Gupta S. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 2005;42:1072-1081
98. Joseph B, Malhi H, Bhargava KK, Palestro CJ, McCuskey RS, Gupta S. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 2002;123: 1677-1685
99. Asonuma K, Gilbert JC, Stein JE, Takeda T, Vacanti JP. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg 1992;27:298-301.
100. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med 2001?138:298-312
101. Chamberlain J, Yamagami T, Colletti E, Theise ND, Desai J, Frias A et al. Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology 2007;46:1935-1945
102. Seo M., Such SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005;328:258-264
103. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH et al. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 2005 ;330:1153-1161
104. Ong SY, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 2006;12:3477-3485
105. Fox IJ, Strom SC. 2008. To be or not to be: generation of hepatocytes from cells outside the liver. Gastroenterology 2008;134:878-881
106. Costa RH, Kalinichenko VV, Holterman AX, Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003;38:1331-1347
107. Yamamoto Y, Banas A, Murata, S, Ishikawa M, Lim CR, Teratani T et al. A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J 2008;275:1260-1273
108. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-1426
109. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulmimant hepatic failure. PLoS One 2007;2:e941.
110. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634-1643
111. Aziz MTA, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH etal. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007;40:893-899
112. Zhao DC, Le JX, Chen R, Yu WH, Zhang XM, Li SN, Xiang P. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rat. World J Gastroentrol 2005; 14:3431-3440
113. Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J, Xu Y, Gautam SC, Chopp M. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathol 2002;22: 275-279
114. Trim, N., Morgan, S., Evans, M., Issa, R., Fine, D., Afford, S. et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol 2000;156:1235-1243
115. Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G et al. Evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol 2003;163:1849-1858
116. Asai K, Tamakawa S, Yamamoto M, Yoshie M, Tokusashi Y, Yaginuma Y et al Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation. Liver Int 2006;26:595-603.
117. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006; 130:1807-1821
118. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M et al. Bone marrow-derived cells express matrix metallopro-teinases and contribute to regression of liver fibrosis in mice. Hepatology 2007;45:213-222
119. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ et al Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix met-alloproteinase inhibition. J Biol Chem 2002;277:11069-11076
120. Xu X, Xu Z, Xu Y, Cui G. Effects of mesenchymal stem cell transplantation on extracellular metrix after myocardial infarction in rats. Corn Artery Dis 2005;16:245-255
121. Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, Wood KJ. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 2009;58:1797-1806
122. di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008;57:223-231
123. Carvalho AB, Quintannilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008;26:1307-1314
124. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L etal. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234
125. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 2007; 20:77-84.
126. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C, Sokal EM. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 2007;16:717-728
127. Piscaglia AC, Shupe TD, Oh SH, Gasbarrini A, Petersen BE. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007;133:619-631
128. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Haematol 2005;33:108-119
129. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110:3499-3506
130. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts Al et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted actions of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-150
131. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007;56:716-724
132. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24: 2292-2298
133. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch. Iran Med 2007; 10,459-466 (Pubitemid 350001896)
134. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N et al. Phase 1 human trial of autologous bone mar-row-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J. Gastroenterol 2007;13; 3359-3363 (Pubitemid 47062247)
135. Pearson, H., 2006. Stem-cell tagging shows flaws. Nature 439,519.
136. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009;21:1199-1205
137. + bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171-179
138. Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19
139. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007;13:1067-1073
140. PaiM, Zacharoulis D, MilicevicMN, HelmyS, JiaoLR, Levicar N, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008;103:1952-1958
141. Gasbarrini A, Rapaccini GL, Rutella S, Zocco MA, Tittoto P, Leone G et al. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 2007;39:878-882
142. Peng L, Li H, Gu L, Peng XM, Huang YS, Gao ZL. Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults. World J Gastroenterol 2007;13:1743-1746
143. Fox IJ, Strom SC. To be or not to be: generation of hepatocytes from cells outside the liver. Gastroenterology 2008;134:878-881
144. Zhang ZX, Guan LX, Zhang K, Wang S, Cao PC, Wang YH et al. Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biol Int 2007;31:645-648
145. Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky H.L, Naishadham D, Sterling RK et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008; 47:789-798
146. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111-2121
147. Xu YQ, Liu ZC. Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Rev 2008; 4:101-112